| 11834472 |
Anti-IL-22 antibodies, antibody fragments, their immunoconjugates and uses thereof |
Jay M. Short, Gerhard Frey, Hwai Wen Chang |
2023-12-05 |
$1,582,000 |
| 9856323 |
Anti-CD22 antibodies |
Jay M. Short, Gerhard Frey, Hwai Wen Chang |
2018-01-02 |
|
| 8455629 |
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
Eugene Medlock, John K. Sullivan, Robin L. Elliott, Frank Martin, Haichun Huang |
2013-06-04 |
$86,106,000 |
| 8409578 |
Methods for treating bone loss with antibodies to OPGL |
Francis H. Martin, Jose Corvalan, C. Geoffrey Davis |
2013-04-02 |
$167,357,000 |
| 8367063 |
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
Eugene Medlock, John K. Sullivan, Robin L. Elliott, Frank Martin, Haichun Huang |
2013-02-05 |
$107,369,000 |
| 8058418 |
Polynucleotides encoding heavy and light chains of antibodies to OPGL |
Francis H. Martin, Jose Corvalan, C. Geoffrey Davis |
2011-11-15 |
$81,085,000 |
| 7923008 |
Methods for decreasing osteoclast formation or bone resorption using an antibody to osteoprotegerin binding protein |
— |
2011-04-12 |
$249,565,000 |
| 7807795 |
Antibodies to osteoprotegerin binding proteins |
— |
2010-10-05 |
$125,969,000 |
| 7718776 |
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
Eugene Medlock, John Sullivan, Robin L. Elliott, Frank Martin, Haichun Huang |
2010-05-18 |
$344,902,000 |
| 7632922 |
Osteoprotegerin |
David L. Lacey, Frank J. Calzone, Ming-Shi Chang |
2009-12-15 |
$441,143,000 |
| 7544519 |
Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators |
Hailing Hsu, Scott Kenneth Wooden |
2009-06-09 |
$156,145,000 |
| 7364736 |
Antibodies to OPGL |
Francis H. Martin, Jose Corvalan, C. Geoffrey Davis |
2008-04-29 |
$154,205,000 |
| 7097834 |
Osteoprotegerin binding proteins |
— |
2006-08-29 |
$380,713,000 |
| 7005413 |
Combination therapy for conditions leading to bone loss |
David L. Lacey, Frank J. Calzone, Ming-Shi Chang |
2006-02-28 |
$571,400,000 |
| 6852839 |
Fhm, a novel member of the TNF ligand supergene family |
Hailing Hsu, Scott Kenneth Wooden |
2005-02-08 |
$171,744,000 |
| 6613544 |
Osteoprotegerin |
David L. Lacey, Frank J. Calzone, Ming-Shi Chang |
2003-09-02 |
$537,667,000 |
| 6521422 |
Fhm, a novel member of the TNF ligand supergene family |
Hailing Hsu, Scott Kenneth Wooden |
2003-02-18 |
$705,715,000 |
| 6479250 |
Eck receptor ligands |
Timothy D. Bartley, Gary M. Fox, Andrew A. Welcher, Ella Magal, Richard A. Lindberg +1 more |
2002-11-12 |
$625,380,000 |
| 6369027 |
Osteoprotegerin |
David L. Lacey, Frank J. Calzone, Ming-Shi Chang |
2002-04-09 |
$252,081,000 |
| 6316408 |
Methods of use for osetoprotegerin binding protein receptors |
— |
2001-11-13 |
$561,122,000 |
| 6288032 |
Osteoprotegerin |
David L. Lacey, Frank J. Calzone, Ming-Shi Chang |
2001-09-11 |
|
| 6284485 |
Nucleic acids encoding osteoprotegerin |
David L. Lacey, Frank J. Calzone, Ming-Shi Chang |
2001-09-04 |
$272,703,000 |
| 6284728 |
Osteoprotegerin |
David L. Lacey, Frank J. Calzone, Ming-Shi Chang |
2001-09-04 |
$272,703,000 |
| 6284740 |
Osteoprotegerin |
David L. Lacey, Frank J. Calzone, Ming-Shi Chang |
2001-09-04 |
$272,703,000 |
| 6175024 |
Synthesis of functionalized esters |
Indira Reddy, Zhenrong Qian, Heng Su, David Ryckman |
2001-01-16 |
$51,366,000 |